Global Swab and Viral Transport Medium Market is valued approximately USD XX billion in 2019 and is anticipated to grow with a healthy growth rate of more than XXX % over the forecast period 2020-2027. Swab and Viral Transport Medium is a collection and transport system used for long-term freezing, transport, collection of clinical specimens containing viruses such as mycoplasma, Covid-19, chlamydia and urea plasma organisms. Also, the swab and viral transport is an implement lightly rubbed against the vesicles or skin to collect sample and these sample is later sent to laboratories in transport medium. In addition, research institutes and labs have intensified their production for covid-19 vaccines, also key market players in the market have increased their production capacities in order to develop useful for viral collection. In addition, the key players are focusing on strategies such as product launch, innovation and merger & acquisition to sustain themselves amidst fierce competition. Further, the growth of the swab viral transport medium market is attributed owing to the rising prevalence of covid-19, high investment in diagnostics kits and accessories along with the rise in use of viral transport medium in microbiology and diagnostic laboratories. As per the World Health Organization, there are around 19,718,030 confirmed cases of covid-19 along with 728,013 deaths globally. As a result, the demand and adoption of swab viral transport medium owing to the increased demand for diagnostics testing services would increase thereby, aiding the growth of the market. However, issue related with false negatives and reinfection is hampering the growth of the market during the forecast period of 2020-2027.

The regional analysis of global Swab and Viral Transport Medium market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region due to the rapid increase in number of diagnostic tests for COVID-19, presence of prominent players, and exponential rise in number of COVID-19 cases in the U.S. Whereas Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:
Thermo Fisher Scientific
Becton, Dickinson and Company (BD)
MWE
Titan Biotech Ltd.
Copan Diagnostics, Inc.
MANTACC
Puritan Medical Products
Yocon Biology
Trinity Biotech
Vircell S.L.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Viral Transport Medium
Virus Swabs
By Indication:
Influenza
Respiratory syncytial virus
Mumps Virus
Adenovirus
Rhinovirus
Herpes Simplex Virus
Varicella-Zoster Virus
Other Indication
By End-User:
Diagnostic Laboratories
Hospitals & ASCs
Specialty Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018
Base year - 2019
Forecast period - 2020 to 2027

Target Audience of the Global Swab and Viral Transport Medium Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors